CNBC's Jim Cramer explains why he is watching shares of Celgene.» Read More
Futures shaved their losses Tuesday following a parade of better-than-expected economic news, but gains were limited amid ongoing worries over the euro zone crisis.
CNBC's Steve Liesman & Rick Santelli breakdown the PPI and retail sales data from October.
Insight on what spin-off companies are worth and what their values are, with Mario Gabelli, GAMCO Investors, Inc. chairman/CEO/CIO
A look at why Ponzi schemes are emerging more now than ever, with Bart Chilton, Commodities Futures Trading Commission (CFTC) commissioner.
There are strong areas of opportunity to invest in now, says Mario Gabelli, GAMCO Investors, Inc. chairman/CEO/CIO, who shares his strategies to make money.
Insight on what growing business was like when he started, with Mario Gabelli, GAMCO Investors, Inc. chairman/CEO/CIO, who weighs in on Occupy Wall Street protesters and the need for businesses to get back to being competitive.
Insight on why contagion risk from developed markets to emerging markets is greater than it appears, with Greg Peters, Morgan Stanley chief cross-asset strategist.
Investors were getting constructive last week and those trades have gone sour, says Kevin Ferry, Cronus Futures Management, who says he is watching the Libor for both dollars and euros.
Larry Hatheway, Chief Economist of UBS, told CNBC, "I think from a markets perspective there are two reasons to believe that 2012 will resemble 2011."
Richard Longdon, CEO of Aveva, told CNBC, "we are concentrating on the markets far away from Europe for our growth longer term but we are really delighted in growth in new products, that¿s the big story for us this time, more than 50% growth is in our new products."
The US dollar will be a "winner" in 2012, and Europe will enter recession in the first half of the year, Geoffrey Yu, foreign exchange strategist at UBS, told CNBC.
Sebastian Evans, fund manager at Naos Asset Management, discusses the hidden value in Village Roadshow's film production business, Engenco's good turnaround track record, and Tissue Therapies' potential partnership deal.
Europe could keep markets on a short leash Tuesday.
Stocks lost 75 points in thin trading on Monday, but is the US economy better than investors think? Jeffrey Kleintop, LPL Financial chief market strategist, and Michael Ozanian, Forbes executive editor, weigh in.
Mad Money host Jim Cramer shares his final thoughts of the day, on Warren Buffett, and Mark Cuban.
MagnaChip is a super cheap chip stock, selling at just 5 times forward earnings, says Mad Money's Cramer. The company could stand to profit from the new Samsung Galaxy, and is a terrific speculative way to play an orphan stock with a ton of potential, but only at the right price, and "right" price means $7.75/share or less.
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
Could an $8 stock be more "expensive" than a $67 stock? Mad Money's Cramer, takes a look at two stocks in the same sector; SuperValu and Whole Foods, and shows investors why it's important to take the stock's growth rate into account by looking at the PEG ratio when comparing price.
Mad Money's Jim Cramer, discusses the profitability and future of nat gas fuel for vehicles, with Andrew Littlefair, Clean Clean Energy Fuels president/CEO.
Mad Money host Jim Cramer says Monday's markets saw a titanic match-up between two heavyweights: Warren Buffett & Italy. Unfortunately, Italy won.